Medical Services aims for 2 million VScan HIV tests in Caribbean:
This article was originally published in Clinica
Executive Summary
Medical Services International (MSI) expects to sell up to 2 million VScan HIV test kits per year in the Caribbean, as it expands its presence in the region. Following the company's success in Belize, where it is extending its distribution network, it has also begun to distribute the kits in Haiti. The VScan kit is undergoing further testing as part of the approval process in Jamaica and has begun testing in the Dominican Republic. The Caribbean has a permanent population of 14 million; the region's transient population stands at around 24 million per year. The Edmonton, Alberta company's forecast is based on a reported 20% incidence of HIV in the region.
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.